Cargando…
L-DOPA Is an Endogenous Ligand for OA1
Albinism is a genetic defect characterized by a loss of pigmentation. The neurosensory retina, which is not pigmented, exhibits pathologic changes secondary to the loss of pigmentation in the retina pigment epithelium (RPE). How the loss of pigmentation in the RPE causes developmental defects in the...
Autores principales: | Lopez, Vanessa M, Decatur, Christina L, Stamer, W. Daniel, Lynch, Ronald M, McKay, Brian S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2553842/ https://www.ncbi.nlm.nih.gov/pubmed/18828673 http://dx.doi.org/10.1371/journal.pbio.0060236 |
Ejemplares similares
-
Comment on “Identification of Novel G Protein–Coupled Receptor 143 Ligands as Pharmacologic Tools for Investigating X-Linked Ocular Albinism”
por: McKay, Brian S., et al.
Publicado: (2017) -
Parkinson’s disease, L-DOPA, and endogenous morphine: A revisit
por: Stefano, George B., et al.
Publicado: (2012) -
L-DOPA
por: Hornykiewicz, Oleh
Publicado: (2017) -
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson’s Disease
por: Bello, Fabio Del, et al.
Publicado: (2019) -
L-Dopa and Behavior
por: Kebabian, John
Publicado: (1974)